首页|阿尔茨海默病外周血早期生物标志物及其分析方法研究进展

阿尔茨海默病外周血早期生物标志物及其分析方法研究进展

扫码查看
阿尔茨海默病(AD)是一种起病隐匿、病理复杂的神经退行性疾病。AD患者临床确诊时通常已发展到中晚期。蛋白标志物在AD发展极早期即从脑脊液穿越血脑屏障进入外周循环。外周血标志物检测具有采集方便、创伤小的特点,有望成为最具潜力的早期筛查和随诊手段。然而传统免疫分析方法无法实现外周血中超微量蛋白标志物的精准定量分析,近年来发展的免疫分析新技术被广泛应用于超微量蛋白标志物分析。该文就AD早期外周血生物标志物的研究进展及其分析方法进行了综述。
Current advances in early peripheral blood biomarkers and their analysis methods for Alzheimer's disease
Alzheimer's disease(AD)is a neurodegenerative disease with a hidden onset and complex pa-thology.The clinical diagnosis of AD has probably developed to the middle or late stage.The relative protein biomarkers in the cerebrospinal fluid can pass through the blood-brain barrier and participate the peripheral circulation in the very early stage of AD.Peripheral blood biomarker detection has the characteristics of con-venient collection and minimal trauma,and is expected to become the most promising early screening and fol-low-up method.However,the traditional immunoassay methods cannot meet the demand for the accurate quantitative analysis of ultra-trace protein biomarkers in peripheral blood.In recent years,the newly developed immunoassay techniques in recent years have been widely applied in the analysis of ultra trace protein biomar-kers.The paper reviews the recent research progress and analysis methods of early peripheral blood biomark-ers of AD.

Alzheimer's diseaseEarly detectionBlood-derived biomarkersImmunoassayReview

祁艳、张臻昊、刘玉、刘欣梦、陈娜娜、劳可静

展开 >

西安医学院/基础与转化医学研究所,陕西 西安 710000

阿尔茨海默病 早期诊断 血液生物标志物 免疫分析方法 综述

国家自然科学基金陕西省教育厅专项科研项目陕西省卫生健康科研基金陕西省自然科学基础研究计划陕西省科协青年人才托举计划

2210412221JK08952021D0462023-JC-QN-013720220610

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(8)
  • 63